Increased hTR expression during transition from adenoma to carcinoma is not associated with promoter methylation

Digestive Diseases and Sciences

Volumn 49, Issue 9, 2004, Pages 1504-1512

  Nakamura, Atsuo ^a   Suda, Takeshi ^a   Honma, Terasu ^a   Takahashi, Toru ^a   Igarashi, Masato ^a   Waguri, Nobuo ^a   Kawai, Hirokazu ^a   Mita, Yusaku ^a   Aoyagi, Yutaka ^a  

^a Grad Sch Med Dent Sci K   (Japan)

Author keywords

colorectal cancer; CpG island; human telomerase reverse transcriptase; human telomerase RNA component; telomerase

Indexed keywords

GENE PRODUCT; TELOMERASE REVERSE TRANSCRIPTASE; TELOMERASE RNA COMPONENT; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ADENOMA; ARTICLE; CANCER GROWTH; CARCINOMA; COLON ADENOMA; COLON CARCINOMA; COLON MUCOSA; CONTROLLED STUDY; GENE; GENE EXPRESSION; HUMAN; HUMAN TELOMERASE REVERSE TRANSCRIPTASE GENE; HUMAN TELOMERASE RNA COMPONENT GENE; HUMAN TISSUE; IN SITU HYBRIDIZATION; METHYLATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; ADENOMA; BASE SEQUENCE; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; METHYLATION; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; TELOMERASE;

EID: 4644221456     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:DDAS.0000042256.89282.c4     Document Type: Article

References (48)

1. Blackburn EH, Greider CW: Telomeres. New York: Cold Spring Harbor Laboratory Press, 1995
2. Harley CB, Futcher AB, Greider CW: Telomeres shorten during aging of human fibroblasts. Nature 345:458-460, 1990
3. Kim NW, Piatyszek MA, Prowse KR, Harley CB, WestMD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015, 1994
4. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE: Extension of life-span by introduction of telomerase into normal humans. Science 279:349-352, 1998
5. Greider CW, Blackburn EH: Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43:405-413, 1985
6. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrews WH, Greider CW, Villeponteau B: The RNA component of human telomerase. Science 269:1236-1241, 1995
7. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB, Cech TR: Telomerase catalytic subunit homologs from fission yeast and human. Science 277:955-959, 1997
8. Nakayama J, Saito M, Nakamura H, Matsuura A, Ishikawa F: TLP1: A gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell 88:875-884, 1997
9. Harrington L, McPhail T, Mar V, Zhou W, Oulton R, Bass MB, Arruda I, Robinson MO: A mammalian telomerase-associated protein. Science 275:973-977, 1997
10. Weinrich SL, Pruzan R, Ma L, Ouellette M, Tesmer VM, Holt SE, Bodnar AG, Lichtsteiner S, Kim NW, Trager JB, Taylor RD, Carlos R, Andrews WH, Wright WE, Shay JW, Harley CB, Morin GB: Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTERT. Nat Gene 17:498-502, 1997
11. Avilion AA, Piatyszekm MA, Gupta J, Shay JW, Bacchetti S, Greider CW: Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 56:645-650, 1996
12. Nakano K, Watney E, McDougall JK: Telomerase activity and expression of telomerase RNA component and telomerase catalytic subunit gene in cervical cancer. Am J Pathol 153:857-864, 1998
13. Takahashi S, Kitamoto M, Takaishi H, Aikata H, Kawakami Y, Nakanishi T, Shimamoto F, Tahara E, Tahara, H, Ide T, Kajiyama G: Expression of telomerase component genes in hepatocellular carcinomas. Eur J Cancer 36:496-502, 2000
14. Kosciolek BA, Kalantidis K, Tabler M, Rowley PT: Inhibition of telomerase activity in human cancer cells by RNA interference. Mol Cancer Ther 2:209-216, 2003
15. Vulliamy T, Marrone A, Szydlo R, Walne A, Mason PJ, Dokal I: Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat Genet 36:447-449, 2004
16. Zhao JQ, Hoare SF, McFarlane R, Muir S, Parkinson EK, Black DM, Keith WN: Cloning and characterization of human and mouse telomerase RNA gene promoter sequences. Oncogene 16:1345-1350, 1998
17. Wick M, Zubov D, Hagen G: Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT). Gene 232:97-106, 1999
18. Razin A, Riggs AD: DNA methylation and gene function. Science 210:604-610, 1980
19. Pogribny IP, Pogribna M, Christman JK, James SJ: Single-site methylation within the p53 promoter region reduces gene expression in a reporter gene construct: Possible in vivo relevance during tumorigenesis. Cancer Res 60:588-594, 2000
20. Cunningham JM, Christensen ER, Tester DJ, Kim CY, Roche PC, Burgart LJ, Thibodeau SN: Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res 58:3455-3460, 1998
21. Feinberg AP, Vogelstein B: Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301:89-92, 1983
22. Lin CH, Hsieh SY, Sheen IS, Lee WC, Chen TC, Shyu WC, Liaw YF: Genome-wide hypomethylation in hepatocellular carcinogenesis. Cancer Res 61:4238-4243, 2001
23. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. Bull WHO 79:373-374, 2001
24. Japanese Society for Cancer of the Colon and Rectum: Japanese Classification of Colorectal Carcinoma, 1st English ed. Tokyo, Kanehara & Co., 1997
25. Raff T, van der Giet M, Endemann D, Wiederholt T, Paul M: Design and testing of beta-actin primers for RT-PCR that do not co-amplify processed pseudogenes. Biotechniques 23:456-460, 1997
26. Hoare SF, Bryce LA, Wisman GB, Burns S, Going JJ, van der Zee AG, Keith WN: Lack of telomerase RNA gene hTERC expression in alternative lengthening of telomeres cells is associated with methylation of the hTERC promoter. Cancer Res 61:27-32, 2001
27. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB: Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93:9821-9826, 1996
28. Yi X, Tesmer V, M Savre-Train I, Shay JW, Wright WE: Both transcriptional and posttranscriptional mechanisms regulate human telomerase template RNA levels. Mol Cell Biol 19:3989-3997, 1999
29. Jones PA: The DNA methylation paradox. Trends Genet 15:34-37, 1999
30. Kuniyasu H, Domen T, Hamamoto T, Yokozaki H, Yasui W, Tahara H, Tahara E: Expression of human telomerase RNA is an early event of stomach carcinogenesis. Jpn J Cancer Res 88:103-107, 1997
31. Heine B, Hummel M, Demel G, Stein H: Demonstration of constant upregulation of the telomerase RNA component in human gastric carcinomas using in situ hybridization. J Patho 185:139-144, 1998
32. Ogami M, Ikura Y, Nishiguchi S, Kuroki T, Ueda M, Sakurai M: Quantitative analysis and in situ localization of human telomerase RNA in chronic liver disease and hepatocellular carcinoma. Lab Invest 79:15-26, 1999
33. Poremba C, Heine B, Diallo R, Heinecke A, Wai D, Schaefer KL, Braun Y, Schuck A, Lanvers C, Bankfalvi A, Kneif S, Torhorst J, Zuber M, Kochli OR, Mross F, Dieterich H, Sauter G, Stein H, Fogt F, Boecker W: Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR. J Patho 198:181-189, 2002
34. Lee RG: Benign tumors of the colon. In Bockus Gastroenterology, 5th ed. WS Haubrich, F Schaffner, JE Berk (eds). Philadelphia, Saunders, 1995, pp 1715-1730
35. Owen DA: Flat adenoma, flat carcinoma, and de novo carcinoma of the colon. Cancer 77:3-6, 1996
36. Hermanek P, Gall FP: Early (microinvasive) colorectal carcinoma pathology, diagnosis, surgical treatment. Int J Colorectal Dis 1:7-84, 1986
37. Shinya H, Wolff WI: Morphology, anatomic distribution and cancer potential of colonic polyps: An analysis of 7000 polyps endoscopically removed. Ann Surg 190:679-683, 1979
38. Stolte M, Bethke B: Colorectal mini-de novo carcinoma: A reality in Germany too. Endoscopy 27:286-290, 1995
39. Shimoda T, Ikegami M, Fujisaki J, Matsui T, Aizawa S, Ishikawa E: Early colorectal carcinoma with special reference to its development de novo. Cancer 64:1138-1146, 1989
40. Hirata I, Tanaka M, Sugimoto K, Yoshizumi M, Umegaki E, Masaki H: Clinicopathological study on flat and depressed minute colorectal carcinomas. Dig Endosc 3:526-535, 1991
41. Iishi H, Kitamura S, Nakaizumi A, Tatsuta M, Otani T, Okuda S: Clinicopathological features and endoscopie diagnosis of superficial early adenocarcinomas of the large intestine. Dig Dis Sci 38:1333-1337, 1993
42. Schlemper RJ, Itabashi M, Kato Y, Lewin KJ, Riddell RH, Shimoda T, Sipponen P, Stolte M, Watanabe H: Differences in the diagnostic criteria used by Japanese and Western pathologists to diagnose colorectal carcinoma. Cancer 82:60-69, 1998
43. Lewin KJ, Riddell RH, Weinstein WM: Gastrointestinal pathology and its clinical implications. New York, Igaku-Shoin, 1992, pp 1256-1257
44. Jass JR, Sobin LH: Histological typing of intestinal tumours. In WHO International Histological Classification of Tumours, 2nd ed. Berlin, Springer-Verlag, 1989, pp 29-40
45. Suda T, Isokawa O, Aoyagi Y, Nomoto M, Tsukada K, Shimizu T, Suzuki Y, Naito A, Igarashi H, Yanagi M, Takahashi T, Asakura H: Quantitation of telomerase activity in hepatocellular carcinoma: A possible aid for a prediction of recurrent diseases in the remnant liver. Hepatology 27:402-406, 1998
46. Chang JT, Chen YL, Yang HT, Chen CY, Cheng AJ: Differential regulation of telomerase activity by six telomerase subunits. Eur J Biochem 269:3442-3450, 2002
47. Henson JD, Neumann AA, Yeager TR, Reddel RR: Alternative lengthening of telomeres in mammalian cells. Oncogene 21:598-610, 2002
48. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR: Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 3:1271-1274, 1997